Effects of glucagon-like peptide-1 receptor agonists on major coronary events in patients with type 2 diabetes.
Xue-Yuan GuoCaihua SangRibo TangChenxi JiangSongnan LiNian LiuDeyong LongXin DuJianzeng DongChangsheng MaPublished in: Diabetes, obesity & metabolism (2023)
In high-risk patients suffering from T2DM, GLP-1RAs were associated with a decrease in MI, especially the human-based and once-weekly GLP-1RAs. No benefit was seen for hospitalization for unstable angina or coronary revascularization. Further research is urgently needed to ascertain improvements in coronary events. This article is protected by copyright. All rights reserved.
Keyphrases
- coronary artery disease
- coronary artery
- percutaneous coronary intervention
- ejection fraction
- end stage renal disease
- aortic stenosis
- coronary artery bypass grafting
- newly diagnosed
- endothelial cells
- chronic kidney disease
- wild type
- prognostic factors
- metabolic syndrome
- heart failure
- atrial fibrillation
- induced pluripotent stem cells
- skeletal muscle
- pluripotent stem cells